MedWatch is the FDA's system for collecting safety reports on generic drugs. Learn how adverse events are reported, why generic manufacturers are often missed, and how patients and providers can help improve drug safety data.
Hip labral tears are a leading cause of hip pain in athletes. Learn how imaging like MRA and arthroscopy diagnose and treat these injuries, why surgery isn't always needed, and what it takes to return to sport safely.
The WHO Model Formulary guides global access to affordable, life-saving generics. Used by over 150 countries, it ensures essential medicines meet strict safety, efficacy, and cost standards-saving millions of lives.
Learn how to tell if new symptoms are from your illness or your medication. Use timing, dose changes, and symptom tracking to avoid misdiagnosis and unnecessary treatments.
Analgesic nephropathy is a preventable kidney disease caused by long-term use of NSAIDs and acetaminophen. Learn how common painkillers damage kidneys, who's at risk, and what safer pain relief options actually work.
Learn how 2025 Medicare Part D formulary changes are forcing generic and biosimilar switches - and what you can do to protect your medication access and avoid costly surprises.
Antacids like Tums and Milk of Magnesia can be dangerous for people with kidney disease. Learn how calcium, aluminum, and magnesium in these meds affect phosphate levels, heart health, and kidney function-and what safer alternatives exist.
Fiber supplements can block absorption of key medications like levothyroxine, metformin, and lithium. Learn how to safely separate doses by 2-4 hours to protect your treatment while still getting the health benefits of fiber.
Phantom limb pain affects 60-85% of amputees and is caused by brain rewiring, not psychology. Mirror therapy and medications like gabapentin and amitriptyline offer real relief-here's how they work.
Biosimilars offer major cost savings and proven safety, but patient hesitation holds them back. Learn why people are unsure, how to talk about them honestly, and what’s changing in 2025 to build trust.